TD Cowen Maintains Rapport Therapeutics(RAPP.US) With Buy Rating
Rapport Therapeutics, Inc. (RAPP) Gets a Buy From TD Cowen
Rapport Therapeutics Analyst Ratings
JonesTrading Initiates Rapport Therapeutics(RAPP.US) With Buy Rating, Announces Target Price $42
Jefferies Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Maintains Target Price $35
Buy Rating Affirmed for Rapport Therapeutics Amid Promising Phase IIa Epilepsy Study and RAP-219's Market Potential
TD Cowen Sticks to Their Buy Rating for Rapport Therapeutics, Inc. (RAPP)
Rapport Therapeutics Analyst Ratings
Buy Rating for Rapport Therapeutics: Disruptive CNS Treatments and Promising Drug Efficacy
No Data
No Data